GeneGlobe ID: SBH0410859 | Cat. No.: | QuantiNova LNA PCR Assays for Real-Time PCR

HS_FNBP1_1654672 QuantiNova LNA PCR Assay

Best coverage assay for FNBP1
Assay targets 7 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.

Select a variant to see the price

Product Specification

null
Assay name​
HS_FNBP1_1654672 QuantiNova LNA PCR Assay
Assay specification​
Best coverage assay for FNBP1
Assay targets 7 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.
Gene symbol​
FNBP1
Gene aliases​
FBP17;KIAA0554
Species​
Homo sapiens
Main target​
ENST00000446176
Exons numbers​
12-13
Ensembl exons ids​
ENSE00001177865;ENSE00000927329
Amplicon start​
1494
Amplicon length​
102
Assay targets​
Transcript Ensembl Id
Bio Type
Ccds
Ref Seq
Chromosome Location
ENST00000355681
Protein coding
CCDS87699
Chr.9: 129895812 - 130043167
ENST00000420781
Protein coding
Chr.9: 129887187 - 130043194
ENST00000443566
Protein coding
Chr.9: 129887187 - 130043194
ENST00000446176
Protein coding
CCDS48040
NM_015033
Chr.9: 129887187 - 130043189
ENST00000449089
Protein coding
Chr.9: 129895268 - 129994867
ENST00000462766
Processed transcript
Chr.9: 129899993 - 129916243
ENST00000478129
Processed transcript
Chr.9: 129899968 - 129927227
Introducing the HS_FNBP1_1654672 QuantiNova LNA PCR Assay, a cutting-edge addition to our QuantiNova LNA PCR Assays for Digital PCR lineup, specifically designed for Digital PCR applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the HS_FNBP1_1654672 QuantiNova LNA PCR Assay facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting Digital PCR, or any other sophisticated analyses, this product from our QuantiNova LNA PCR Assays for Digital PCR collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with HS_FNBP1_1654672 QuantiNova LNA PCR Assay and elevate your work to new heights.